Zensar Technologies Limited (NSE:ZENSARTECH), is not the biggest company in the market, but it has seen a significant share price move over the past few months on the NSEI, hitting highs of ₹387 and falling at lows of ₹263. Certain movements in the stock price can give investors a better opportunity to get into the stock and potentially buy at a lower price. A question to be answered is whether Zensar Technologies’ current trading price of ₹263 reflects the true value of the small cap? Or is it currently undervalued, giving us the opportunity to buy? Let’s take a look at the outlook and value of Zensar Technologies based on the most recent financial data to see if there are any catalysts for a price change.
Check out our latest analysis for Zensar Technologies
Is Zensar Technologies still cheap?
Good news, investors! Zensar Technologies is still a good deal right now according to my multiple price model, which compares the company’s price-to-earnings ratio to the industry average. I used the price/earnings ratio in this case because there is not enough visibility to predict its cash flow. The stock’s ratio of 14.31x is currently well below the industry average of 27.16x, meaning it is trading at a lower price than its peers. Another thing to keep in mind is that Zensar Technologies’ stock price is quite stable compared to the rest of the market, as indicated by its low beta. This means that if you think the current stock price should move closer to its industry peers, a low beta could suggest that it is unlikely to reach that level anytime soon, and once there will be, it can be difficult to fall back into an attractive purchase. worn again.
What does the future of Zensar Technologies look like?
Future prospects are an important aspect when considering buying a stock, especially if you are an investor looking to grow your portfolio. Although value investors argue that it is intrinsic value relative to price that matters most, a more compelling investment thesis would be high growth potential at a cheap price. Zensar Technologies’ earnings over the next few years are expected to increase by 31%, indicating a very optimistic future. This should lead to more robust cash flow, fueling higher share value.
What does this mean to you :
Are you a shareholder? Given that ZENSARTECH is currently trading below the industry PE ratio, now may be the perfect time to accumulate more of your holdings in the stock. With an optimistic earnings outlook on the horizon, it appears that this growth has yet to be fully priced into the stock price. However, there are also other factors such as financial health to consider, which could explain the current price multiple.
Are you a potential investor? If you’ve been keeping an eye on ZENSARTECH for a while, it might be time to get into the stock. Its buoyant future earnings outlook is not yet fully reflected in the current share price, which means it is not too late to buy ZENSARTECH. But before making investment decisions, consider other factors such as the track record of its management team, in order to make an informed investment decision.
If you want to dig deeper into Zensar Technologies, you should also look into the risks it currently faces. Every business has risks, and we’ve spotted 2 warning signs for Zensar Technologies you should know.
If you are no longer interested in Zensar Technologies, you can use our free platform to view our list of over 50 other stocks with high growth potential.
Feedback on this article? Concerned about content? Get in touch with us directly. You can also email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.